001     140144
005     20240321220743.0
024 7 _ |a 10.1016/j.conb.2018.02.024
|2 doi
024 7 _ |a pmid:29544200
|2 pmid
024 7 _ |a 0959-4388
|2 ISSN
024 7 _ |a 1873-6882
|2 ISSN
024 7 _ |a altmetric:34407701
|2 altmetric
037 _ _ |a DZNE-2020-06466
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Blanquie, Oriane
|0 P:(DE-2719)2812409
|b 0
|e First author
|u dzne
245 _ _ |a Cytoskeleton dynamics in axon regeneration.
260 _ _ |a Philadelphia, Pa.
|c 2018
|b Current Biology
264 _ 1 |3 print
|2 Crossref
|b Elsevier BV
|c 2018-08-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1685012325_32154
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Recent years have seen cytoskeleton dynamics emerging as a key player in axon regeneration. The cytoskeleton, in particular microtubules and actin, ensures the growth of neuronal processes and maintains the singular, highly polarized shape of neurons. Following injury, adult central axons are tipped by a dystrophic structure, the retraction bulb, which prevents their regeneration. Abnormal cytoskeleton dynamics are responsible for the formation of this growth-incompetent structure but pharmacologically modulating cytoskeleton dynamics of injured axons can transform this structure into a growth-competent growth cone. The cytoskeleton also drives the migration of scar-forming cells after an injury. Targeting its dynamics modifies the composition of the inhibitory environment formed by scar tissue and renders it more permissive for regenerating axons. Hence, cytoskeleton dynamics represent an appealing target to promote axon regeneration. As some of cytoskeleton-targeting drugs are used in the clinics for other purposes, they hold the promise to be used as a basis for a regenerative therapy after a spinal cord injury.
536 _ _ |a 341 - Molecular Signaling (POF3-341)
|0 G:(DE-HGF)POF3-341
|c POF3-341
|f POF III
|x 0
542 _ _ |i 2018-08-01
|2 Crossref
|u https://www.elsevier.com/tdm/userlicense/1.0/
542 _ _ |i 2018-03-01
|2 Crossref
|u http://creativecommons.org/licenses/by-nc-nd/4.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Axons: metabolism
|2 MeSH
650 _ 2 |a Cell Movement
|2 MeSH
650 _ 2 |a Cicatrix: metabolism
|2 MeSH
650 _ 2 |a Cicatrix: pathology
|2 MeSH
650 _ 2 |a Cicatrix: physiopathology
|2 MeSH
650 _ 2 |a Cytoskeleton: metabolism
|2 MeSH
650 _ 2 |a Growth Cones: physiology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Nerve Regeneration: physiology
|2 MeSH
700 1 _ |a Bradke, Frank
|0 P:(DE-2719)2810270
|b 1
|e Last author
|u dzne
773 1 8 |a 10.1016/j.conb.2018.02.024
|b : Elsevier BV, 2018-08-01
|p 60-69
|3 journal-article
|2 Crossref
|t Current Opinion in Neurobiology
|v 51
|y 2018
|x 0959-4388
773 _ _ |a 10.1016/j.conb.2018.02.024
|g Vol. 51, p. 60 - 69
|0 PERI:(DE-600)2013035-1
|q 51<60 - 69
|p 60-69
|t Current opinion in neurobiology
|v 51
|y 2018
|x 0959-4388
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/140144/files/DZNE-2020-06466.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/140144/files/DZNE-2020-06466.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:140144
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2812409
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2810270
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-341
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Molecular Signaling
|x 0
914 1 _ |y 2018
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-03-30
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CURR OPIN NEUROBIOL : 2021
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-03-30
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1120
|2 StatID
|b BIOSIS Reviews Reports And Meetings
|d 2023-03-30
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CURR OPIN NEUROBIOL : 2021
|d 2023-03-30
920 1 _ |0 I:(DE-2719)1013002
|k AG Bradke
|l Axon Growth and Regeneration
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013002
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21